Associations between polygenic risk for psychiatric disorders and substance involvement

Frontiers in Genetics

Volumn 7, Issue AUG, 2016, Pages

  Carey, Caitlin E ^a   Agrawal, Arpana ^b   Bucholz, Kathleen K ^b   Hartz, Sarah M ^b   Lynskey, Michael T ^c   Nelson, Elliot C ^b   Bierut, Laura J ^b   Bogdan, Ryan ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabis; Cocaine; Comorbidity; Depression; Polygenic; Schizophrenia; Substance

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CANNABIS USE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DEPENDENCE; DSM-IV; FEMALE; GENERAL SUBSTANCE INVOLVEMENT FACTOR; GENETIC RISK; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MENTAL DISEASE ASSESSMENT; META ANALYSIS (TOPIC); OPIATE ADDICTION; POLYGENIC RISK SCORE; SCHIZOPHRENIA; SCORING SYSTEM; SUBSTANCE USE;

EID: 84988372951     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2016.00149     Document Type: Article

References (65)

1. Abdallah, M. W., Greaves-Lord, K., Grove, J., Norgaard-Pedersen, B., Hougaard, D. M., and Mortensen, E. L. (2011). Psychiatric comorbidities in autism spectrum disorders: findings from a Danish Historic Birth Cohort. Eur. Child Adolesc. Psychiatry 20, 599-601. doi: 10.1007/s00787-011-0220-2.
2. Agrawal, A., and Lynskey, M. T. (2014). Cannabis controversies: how genetics can inform the study of comorbidity. Addiction 109, 360-370. doi: 10.1111/add.12436.
3. Agrawal, A., Verweij, K. J., Gillespie, N. A., Heath, A. C., Lessov-Schlaggar, C. N., Martin, N. G., et al. (2012). The genetics of addiction-a translational perspective. Transl. Psychiatry 2:e140. doi: 10.1038/tp.2012.54.
4. Arseneault, L., Cannon, M., Witton, J., and Murray, R. M. (2004). Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry 184, 110-117. doi: 10.1192/bjp.184.2.110.
5. Biederman, J., Faraone, S. V., Wozniak, J., and Monuteaux, M. C. (2000). Parsing the association between bipolar, conduct, and substance use disorders: a familial risk analysis. Biol. Psychiatry 48, 1037-1044. doi: 10.1016/S0006-3223(00)00906-9.
6. Bienvenu, O. J., Davydow, D. S., and Kendler, K. S. (2011). Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence. Psychol. Med. 41, 33-40. doi: 10.1017/S003329171000084X.
7. Bierut, L. J., Agrawal, A., Bucholz, K. K., Doheny, K. F., Laurie, C., Pugh, E., et al. (2010). A genome-wide association study of alcohol dependence. Proc. Natl. Acad. Sci. U.S.A. 107, 5082-5087. doi: 10.1073/pnas.0911109107.
8. Bierut, L. J., Madden, P. A., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O. F., et al. (2007). Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16, 24-35. doi: 10.1093/hmg/ddl441.
9. Bierut, L. J., Strickland, J. R., Thompson, J. R., Afful, S. E., and Cottler, L. B. (2008). Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings. Drug Alcohol Depend. 95, 14-22. doi: 10.1016/j.drugalcdep.2007.11.023.
10. Bogdan, R., Pagliaccio, D., Baranger, D. A., and Hariri, A. R. (2016). Genetic moderation of stress effects on corticolimbic circuitry. Neuropsychopharmacology 41, 275-296. doi: 10.1038/npp.2015.216.
11. Brady, K. T., Lydiard, R. B., Malcolm, R., and Ballenger, J. C. (1991). Cocaine-induced psychosis. J. Clin. Psychiatry 52, 509-512.
12. Bucholz, K. K., Cadoret, R., Cloninger, C. R., Dinwiddie, S. H., Hesselbrock, V. M., Nurnberger, J. I., et al. (1994). A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J. Stud. Alcohol 55, 149-158. doi: 10.15288/jsa.1994.55.149.
13. Buckholtz, J. W., and Meyer-Lindenberg, A. (2012). Psychopathology and the human connectome: toward a transdiagnostic model of risk for mental illness. Neuron 74, 990-1004. doi: 10.1016/j.neuron.2012.06.002.
14. Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., and Lee, J. J. (2015). Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4:7. doi: 10.1186/s13742-015-0047-8.
15. Chang, Z., Lichtenstein, P., and Larsson, H. (2012). The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin study. J. Abnorm. Child Psychol. 40, 425-435. doi: 10.1007/s10802-011-9575-6.
16. Compton, W. M., Thomas, Y. F., Stinson, F. S., and Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 64, 566-576. doi: 10.1001/archpsyc.64.5.566.
17. Cross-Disorder Group of the Psychiatric Genomics Consortium (2013). Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379. doi: 10.1016/S0140-6736(12)62129-1.
18. De Alwis, D., Agrawal, A., Reiersen, A. M., Constantino, J. N., Henders, A., Martin, N. G., et al. (2014). ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins. J. Stud. Alcohol Drugs 75, 211-221. doi: 10.15288/jsad.2014.75.211.
19. Edwards, A. C., Aliev, F., Bierut, L. J., Bucholz, K. K., Edenberg, H., Hesselbrock, V., et al. (2012). Genome-wide association study of comorbid depressive syndrome and alcohol dependence. Psychiatr. Genet. 22, 31-41. doi: 10.1097/YPG.0b013e32834acd07.
20. Edwards, A. C., Maes, H. H., Pedersen, N. L., and Kendler, K. S. (2011). A population-based twin study of the genetic and environmental relationship of major depression, regular tobacco use and nicotine dependence. Psychol. Med. 41, 395-405. doi: 10.1017/S0033291710000589.
21. Elkins, I. J., McGue, M., and Iacono, W. G. (2007). Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch. Gen. Psychiatry 64, 1145-1152. doi: 10.1001/archpsyc.64.10.1145.
22. Finucane, H. K., Bulik-Sullivan, B., Gusev, A., Trynka, G., Reshef, Y., Loh, P. R., et al. (2015). Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228-1235. doi: 10.1038/ng.3404.
23. Foroud, T., Edenberg, H. J., Goate, A., Rice, J., Flury, L., Koller, D. L., et al. (2000). Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol. Clin. Exp. Res. 24, 933-945. doi: 10.1111/j.1530-0277.2000.tb04634.x.
24. French, L., Gray, C., Leonard, G., Perron, M., Pike, G. B., Richer, L., et al. (2015). Early cannabis use, polygenic risk score for schizophrenia and brain maturation in adolescence. JAMA psychiatry 72, 1002-1011. doi: 10.1001/jamapsychiatry.2015.1131.
25. Hasin, D., and Kilcoyne, B. (2012). Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC. Curr. Opin. Psychiatry 25, 165-171. doi: 10.1097/YCO.0b013e3283523dcc.
26. Heath, A. C., Martin, N. G., Lynskey, M. T., Todorov, A. A., and Madden, P. A. (2002). Estimating two-stage models for genetic influences on alcohol, tobacco or drug use initiation and dependence vulnerability in twin and family data. Twin Res. 5, 113-124. doi: 10.1375/twin.5.2.113.
27. Henquet, C., Di Forti, M., Morrison, P., Kuepper, R., and Murray, R. M. (2008). Gene-environment interplay between cannabis and psychosis. Schizophr. Bull. 34, 1111-1121. doi: 10.1093/schbul/sbn108.
28. Johnson, C., Drgon, T., McMahon, F. J., and Uhl, G. R. (2009). Convergent genome wide association results for bipolar disorder and substance dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 182-190. doi: 10.1002/ajmg.b.30900.
29. Kendler, K. S., Chen, X., Dick, D., Maes, H., Gillespie, N., Neale, M. C., et al. (2012). Recent advances in the genetic epidemiology and molecular genetics of substance use disorders. Nat. Neurosci. 15, 181-189. doi: 10.1038/nn.3018.
30. Kendler, K. S., McGuire, M., Gruenberg, A. M., O'Hare, A., Spellman, M., and Walsh, D. (1993). The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Arch. Gen. Psychiatry 50, 952-960.
31. Kendler, K. S., Myers, J., and Prescott, C. A. (2007). Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch. Gen. Psychiatry 64, 1313-1320. doi: 10.1001/archpsyc.64.11.1313.
32. Kendler, K. S., Prescott, C. A., Myers, J., and Neale, M. C. (2003). The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry 60, 929-937. doi: 10.1001/archpsyc.60.9.929.
33. Krapohl, E., Euesden, J., Zabaneh, D., Pingault, J. B., Rimfeld, K., von Stumm, S., et al. (2015). Phenome-wide analysis of genome-wide polygenic scores. Mol. Psychiatry doi: 10.1038/mp.2015.126 [Epub ahead of print].
34. Kristjansson, S., McCutcheon, V. V., Agrawal, A., Lynskey, M. T., Conroy, E., Statham, D. J., et al. (2016). The variance shared across forms of childhood trauma is strongly associated with liability for psychiatric and substance use disorders. Brain and behav. 6:e00432. doi: 10.1002/brb3.432.
35. Lancaster, T. M., Linden, D. E., Tansey, K. E., Banaschewski, T., Bokde, A. L., Bromberg, U., et al. (2016). Polygenic risk of psychosis and ventral striatal activation during reward processing in healthy adolescents. JAMA Psychiatry 73, 852-861. doi: 10.1001/jamapsychiatry.2016.1135.
36. Laurie, C. C., Doheny, K. F., Mirel, D. B., Pugh, E. W., Bierut, L. J., Bhangale, T., et al. (2010). Quality control and quality assurance in genotypic data for genome-wide association studies. Genet. Epidemiol. 34, 591-602. doi: 10.1002/gepi.20516.
37. Lee, P. H., O'Dushlaine, C., Thomas, B., and Purcell, S. M. (2012). INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 28, 1797-1799. doi: 10.1093/bioinformatics/bts191.
38. Lee, S. H., Ripke, S., Neale, B. M., Faraone, S. V., Purcell, S. M., Perlis, R. H., et al. (2013). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984-994. doi: 10.1038/ng.2711.
39. Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., and Glass, K. (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin. Psychol. Rev. 31, 328-341. doi: 10.1016/j.cpr.2011.01.006.
40. Lehman, A. F., Myers, C. P., Thompson, J. W., and Corty, E. (1993). Implications of mental and substance use disorders. A comparison of single and dual diagnosis patients. J. Nerv. Ment. Dis. 181, 365-370. doi: 10.1097/00005053-199306000-00005.
41. Lynskey, M. T., Glowinski, A. L., Todorov, A. A., Bucholz, K. K., Madden, P. A., Nelson, E. C., et al. (2004). Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch. Gen. Psychiatry 61, 1026-1032. doi: 10.1001/archpsyc.61.10.1026.
42. Muthén, L. K., and Muthén, B. O. (2015). Mplus User's Guide, 7th Edn. Los Angeles, CA: Mutheìn & Mutheìn.
43. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium (2015). Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18, 199-209.
44. Ng, E., McGirr, A., Wong, A. H., and Roder, J. C. (2013). Using rodents to model schizophrenia and substance use comorbidity. Neurosci. Biobehav. Rev. 37, 896-910. doi: 10.1016/j.neubiorev.2013.03.025.
45. Olfson, E., Edenberg, H. J., Nurnberger, J. Jr., Agrawal, A., Bucholz, K. K., Almasy, L. A., et al. (2014). An ADH1B variant and peer drinking in progression to adolescent drinking milestones: evidence of a gene-by-environment interaction. Alcohol. Clin. Exp. Res. 38, 2541-2549. doi: 10.1111/acer.12524.
46. Pagliaccio, D., Barch, D. M., Bogdan, R., Wood, P. K., Lynskey, M. T., Heath, A. C., et al. (2015). Shared predisposition in the association between cannabis use and subcortical brain structure. JAMA psychiatry 72, 994-1001. doi: 10.1001/jamapsychiatry.2015.1054.
47. Peña-Oliver, Y., Carvalho, F. M., Sanchez-Roige, S., Quinlan, E. B., Jia, T., Walker-Tilley, T., et al. (2016). Mouse and human genetic analyses associate kalirin with ventral striatal activation during impulsivity and with alcohol misuse. Front. Genet. 7:52. doi: 10.3389/fgene.2016.00052.
48. Power, R. A., Verweij, K. J., Zuhair, M., Montgomery, G. W., Henders, A. K., Heath, A. C., et al. (2014). Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol. Psychiatry 19, 1201-1204. doi: 10.1038/mp.2014.51.
49. Prescott, C. A., Aggen, S. H., and Kendler, K. S. (2000). Sex-specific genetic influences on the comorbidity of alcoholism and major depression in a population-based sample of US twins. Arch. Gen. Psychiatry 57, 803-811. doi: 10.1001/archpsyc.57.8.803.
50. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O'Donovan, M. C., Sullivan, P. F., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752. doi: 10.1038/nature08185.
51. Reich, T., Edenberg, H. J., Goate, A., Williams, J. T., Rice, J. P., Van Eerdewegh, P., et al. (1998). Genome-wide search for genes affecting the risk for alcohol dependence. Am. J. Med. Genet. 81, 207-215. doi: 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X.
52. Ron, D., and Barak, S. (2016). Molecular mechanisms underlying alcohol-drinking behaviours. Nat. Rev. Neurosci. doi: 10.1038/nrn.2016.85 [Epub ahead of print].
53. Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A., et al. (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 16, 36-49. doi: 10.1093/hmg/ddl438.
54. Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427. doi: 10.1038/nature13595.
55. Serper, M. R., Alpert, M., Richardson, N. A., Dickson, S., Allen, M. H., and Werner, A. (1995). Clinical effects of recent cocaine use on patients with acute schizophrenia. Am. J. Psychiatry 152, 1464-1469. doi: 10.1176/ajp.152.10.1464.
56. Shaner, A., Eckman, T. A., Roberts, L. J., Wilkins, J. N., Tucker, D. E., Tsuang, J. W., et al. (1995). Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers-a government-sponsored revolving door? N. Engl. J. Med. 333, 777-783. doi: 10.1056/NEJM199509213331207.
57. Sibley, M. H., Pelham, W. E., Molina, B. S., Coxe, S., Kipp, H., Gnagy, E. M., et al. (2014). The role of early childhood ADHD and subsequent CD in the initiation and escalation of adolescent cigarette, alcohol, and marijuana use. J. Abnorm. Psychol. 123, 362-374. doi: 10.1037/a0036585.
58. Smoller, J. W. (2013). Disorders and borders: psychiatric genetics and nosology. Am. J. Med. Genet. B Neuropsychiatr. Genet. 162B, 559-578. doi: 10.1002/ajmg.b.32174.
59. Swann, A. C. (2010). The strong relationship between bipolar and substance-use disorder. Ann. N. Y. Acad. Sci. 1187, 276-293. doi: 10.1111/j.1749-6632.2009.05146.x.
60. Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K. R., et al. (2010). Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 105, 1117-1128. doi: 10.1111/j.1360-0443.2010.02902.x.
61. Volkow, N. D. (2009). Substance use disorders in schizophrenia-clinical implications of comorbidity. Schizophr. Bull. 35, 469-472. doi: 10.1093/schbul/sbp016.
62. Wetherill, L., Agrawal, A., Kapoor, M., Bertelsen, S., Bierut, L. J., Brooks, A., et al. (2015). Association of substance dependence phenotypes in the COGA sample. Addict. Biol. 20, 617-627. doi: 10.1111/adb.12153.
63. Winokur, G., Coryell, W., Akiskal, H. S., Maser, J. D., Keller, M. B., Endicott, J., et al. (1995). Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness, and the primary-secondary distinction. Am. J. Psychiatry 152, 365-372.
64. Yang, B. Z., Han, S., Kranzler, H. R., Farrer, L. A., and Gelernter, J. (2011). A genomewide linkage scan of cocaine dependence and major depressive episode in two populations. Neuropsychopharmacology 36, 2422-2430. doi: 10.1038/npp.2011.122.
65. Yoshimasu, K., Mure, K., Hashimoto, M., Takemura, S., Tsuno, K., Hayashida, M., et al. (2015). Genetic alcohol sensitivity regulated by ALDH2 and ADH1B polymorphisms is strongly associated with depression and anxiety in Japanese employees. Drug Alcohol Depend. 147, 130-136. doi: 10.1016/j.drugalcdep.2014.11.034.